Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer.
Ontology highlight
ABSTRACT: Metabolism reprogramming is considered a hallmark of cancer. The study of bladder cancer (BC) metabolism could be the key to developing new strategies for diagnosis and therapy. This work aimed to identify tissue and urinary metabolic signatures as biomarkers of BC and get further insight into BC tumor biology through the study of gene-metabolite networks and the integration of metabolomics and transcriptomics data. BC and control tissue samples (n = 44) from the same patients were analyzed by High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance and microarrays techniques. Besides, urinary profiling study (n = 35) was performed in the same patients to identify a metabolomic profile, linked with BC tissue hallmarks, as a potential non-invasive approach for BC diagnosis. The metab
SUBMITTER: Loras A
PROVIDER: S-EPMC6562847 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
ACCESS DATA